Infection Prevention Devices Market By Product Type (Infection Prevention Supplies, Infection Prevention Services, Infection Prevention Equipment), End-User (Hospitals, Lifescience Industries, Clinical Laboratories), & Region for 2024-2031
Published Date: August - 2024 | Publisher: MIR | No of Pages: 320 | Industry: latest updates trending Report | Format: Report available in PDF / Excel Format
View Details Download Sample Ask for Discount Request CustomizationInfection Prevention Devices Market By Product Type (Infection Prevention Supplies, Infection Prevention Services, Infection Prevention Equipment), End-User (Hospitals, Lifescience Industries, Clinical Laboratories), & Region for 2024-2031
Infection Prevention Devices Market Valuation – 2024-2031
The increasing need for infection prevention devices is driven by several causes including a global imperative to combat infectious illnesses, improve healthcare outcomes, and improve patient safety. At the heart of this growing demand is the growing risk posed by healthcare-associated infections (HAIs) which continue to affect millions of people globally taking a heavy toll on both human lives and healthcare resources. In response to this critical dilemma, healthcare providers, regulators, and stakeholders are increasingly prioritizing infection prevention techniques resulting in the widespread adoption of novel technologies aimed at reducing the risk of infection in a variety of healthcare settings by enabling the market to surpass a revenue of USD 2.03 Billion valued in 2024 and reach a valuation of around USD 2.91 Billion by 2031.
Rising awareness of HAIs to treat the prevalent chronic diseases among the aging populations is increasing the demand for number of invasive medical operations including surgeries and catheterizations. These treatments are necessary for identifying and treating a variety of conditions and can allow for microbial colonization and eventual illnesses. As a result, there has been a greater emphasis on developing strict infection control protocols and using specialized technologies designed to reduce the danger of microbial transmission in clinical environments by enabling the market to grow at a CAGR of 4.62% from 2024 to 2031. Â
Infection Prevention Devices MarketDefinition/ Overview
Infection prevention devices are a diverse group of tools and technologies aimed at reducing the spread of infectious pathogens in hospital settings and beyond. These devices play an important role in protecting both patients and healthcare workers against pathogen transmission promoting a safer healthcare environment and lowering the prevalence of healthcare-associated illnesses. Personal protective equipment (PPE) such as gloves, masks, gowns, and protection for the face is one type of infection prevention device that acts as a barrier against direct contact with infectious agents.
These devices include a wide range of equipment and technology used to prevent the spread of infectious agents in a variety of healthcare environments. Personal protective equipment (PPE) is one of the most basic applications for infection prevention devices. Masks, gloves, gowns, and face shields are examples of personal protective equipment (PPE) that operate as barriers to direct contact with infectious materials, protecting healthcare workers and patients from pathogen transmission. Also, specialist respirators such as N95 masks provide improved filtration effectiveness which is especially relevant in conditions where airborne transmission of infectious agents is a problem such as with respiratory viruses like influenza or COVID-19.
The use of wearable infection prevention devices has the potential to transform personal protective equipment (PPE) and infection control procedures. Healthcare personnel can use wearable sensors equipped with antimicrobial chemicals to continuously monitor for germs on their skin or clothing. These sensors can detect potential contamination in real time, advising users to take necessary steps such as hand hygiene or changing their PPE.
What's inside a
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
How will Increasing Incidences of Chronic Diseases Drive the Infection Prevention Devices Market?
The increasing global geriatric population combined with an increase in the frequency of chronic diseases among the elderly creates a substantial opportunity for the infection prevention devices industry. As people age, their immune systems deteriorate making them more vulnerable to diseases. This demographic trend has pushed healthcare practitioners to prioritize infection prevention techniques, especially in hospital settings where infection rates are higher. Hospital-associated infections (HAIs) have become a major concern in patient care resulting in a desire for next-generation infection prevention devices that can substantially reduce these risks.
Healthcare institutions are investing much more in developing their capabilities and infrastructure to better meet the needs of an older population. With older persons frequently requiring longer hospital stays for treatment and healing, the significance of effective infection prevention measures cannot be emphasized. These expenditures are aimed not just at improving service quality but also at lowering healthcare-related expenses connected with HAI treatment.
The growing elderly population together with the rising incidence of chronic diseases and an increasing focus on preventive healthcare is driving significant growth in the infection prevention devices market. Healthcare institutions are investing in innovative equipment and procedures to prevent HAIs and improve patient safety. Regulatory mandates and lessons learned from the COVID-19 epidemic have fueled the desire for novel infection prevention systems. As the healthcare landscape advances, infection prevention will remain a primary goal resulting in better results for both patients and healthcare providers.
How will the Lack of Reference of Patients to Visit Hospitals Affect the Infection Prevention Devices Market?
The infection prevention devices market’s expansion plan is hampered by several factors, the most significant of which are changing patient behavior dynamics and technological advancements in healthcare facilities. One important barrier to market expansion is patient’s decreased propensity for seeking medical care in traditional healthcare facilities such as hospitals. The delay is frequently linked to the prohibitively high expenses connected with therapy which prevent people from receiving critical healthcare treatments. As healthcare costs continue to climb, patients are increasingly choosing alternative care choices or delaying treatment completely, reducing demand for infection control equipment in hospital settings.
One such improvement is the advancement of healthcare facility capacities which results in shorter hospital stays for patients. Modern medical practices such as less invasive treatments, ambulatory care, and telemedicine allow for faster recovery and eliminate the need for long-term hospitalization. As a result, shorter patient stays lead to lower adoption of infection control devices in hospital settings, putting additional pressure on market growth. In essence, the combination of cost-related barriers to healthcare access and the optimization of healthcare delivery models through technological advancements presents difficult challenges for the infection prevention devices market demanding strategic adaptation and innovation to maintain growth in the face of changing healthcare landscapes.
Category-Wise Acumens
How will the Increasing Use of Sterilization Products Drive the Medical Waste Disposable Devices Segment?
The medical waste disposable devices category dominated the infection prevention devices market in 2019, and it is expected to increase at a 2.4% annual rate from 2020 to 2025. This growth path is primarily driven by the growing usage of sterilization devices which are critical in preventing the spread of infectious diseases. Sterilization devices play an important role in healthcare settings because they effectively eliminate all bacteria on the surface of medical articles or inside fluids considerably lowering the risk of disease transmission connected with their use. The need for strict sterilization techniques derives from the significant health dangers provided by improperly sanitized important goods which can act as vectors for harmful bacteria.
This notable development pattern is rooted in the critical role performed by sterilizing goods which act as the cornerstone in maintaining the efficacy of medical waste disposal methods. Sterilization products play an important role in healthcare facilities since their principal goal is to eliminate any bacteria that live on the surface of medical goods or are suspended in fluids. By efficiently removing these microorganisms, sterilization products act as barriers to disease transmission, protecting both healthcare providers and patients.
Therefore, the infection prevention devices market notably the medical waste disposable devices sector is expected to continue growing. With an unwavering focus on improving sterilization efficacy, enhancing sterility assurance monitoring techniques, and fostering innovation in infection prevention technologies, healthcare stakeholders are well-prepared to navigate the changing landscape of infectious diseases with confidence and flexibility.
Will the High Probability of Acquiring Infections in Hospital Premises Drive the Hospital Segment?
Hospitals emerged as significant participants in the infection prevention devices market owing to the increased risk of contracting infections in hospital settings. These dangers are mostly caused by the transfer of respiratory or bloodborne infections. As medical facilities become more conscious of the necessity of infection control, there is a greater emphasis on implementing preventive measures to protect patients, visitors, and healthcare workers. The development of patient care services, notably the rise of customized care and the establishment of urgent care and primary care clinics represents a broader trend toward more accessible healthcare at all levels of the hospital.
The increasing focus on proactive healthcare measures is one of the primary drivers of the life sciences industry segment’s rapid expansion. Healthcare providers and politicians alike recognize the importance of avoiding infections rather than treating them once they develop. This preventative approach not only improves patient outcomes but also lessens the strain on healthcare systems by slowing the spread of infectious diseases.
Therefore, hospitals play a critical role in generating demand for infection-prevention devices by striving to maintain the highest levels of patient safety. The rise of mobile clinical care centers and the expansion of tailored patient care are transforming the healthcare environment, opening up new avenues for infection prevention technologies. Within this dynamic climate, the life sciences industries segment stands out as a vital driver of innovation with the potential to transform the way we prevent and manage infectious diseases. Lifescience firms are paving the road for a safer and healthier future by continuing to invest in R&D, collaborating across industries, and committing to proactive healthcare policies
Gain Access into Infection Prevention Devices Market Report Methodology
Country/Region-wise Acumens
How will the Increasing Surgical Procedures and Hospital Admissions Drive the Market in North America?
North America’s region is expected to dominate throughout the forecast period due to leading industry players to broaden their product portfolios through strategic partnerships. By collaborating, these companies hoped to capitalize on synergies and improve their products in infection prevention technologies. This proactive approach not only strengthened their competitive advantage but also helped to increase the regional market.
The evolution of patient care models particularly the introduction of individualized care has transformed the healthcare scene in the region. The construction of urgent care clinics and primary care facilities represents a shift toward decentralized healthcare delivery that prioritizes accessibility and efficiency. However, with increasing decentralization comes the critical requirement for strong infection prevention measures to reduce the risk of disease transmission across these many healthcare settings. Manufacturers of infection prevention devices are inventing and diversifying their product offerings to meet new demands and problems. UV-C disinfection systems, antimicrobial coatings, and automated sterilizing equipment are becoming more important components of comprehensive infection control measures. These technologies not only improve the effectiveness of infection control measures but also streamline operations and maximize resource consumption, promoting sustainability in healthcare delivery.
Therefore, North America’s dominance in the infection prevention devices market is fueled by several factors including increased surgical operations, strategic collaborations among industry players, and the evolution of patient care models. The emergence of decentralized clinical care facilities as well as the increased emphasis on infection control in numerous industries are driving demand for novel infection prevention technologies.
Will the Increasing Expenditure Boost the Asia Pacific Region?
The Asia Pacific region is witnessing a spectacular expansion in the presence of outsourcing businesses as well as a significant increase in healthcare spending and the continued evolution of healthcare standards and infrastructure. This dynamic environment is creating a fertile foundation for the spread of infection-prevention devices. The region’s booming outsourcing sector is boosting economic growth while also altering the healthcare landscape by making specialized services and expertise more accessible. As the outsourcing business expands into new sectors including healthcare, there is a noticeable increase in demand for infection control equipment as healthcare facilities look to strengthen their defenses against communicable diseases.
Another major factor driving demand for infection prevention devices is the evolution of healthcare standards and infrastructure in the Asia Pacific region. As healthcare systems attempt to meet worldwide standards and best practices, there is a rising realization of the crucial need for effective infection control methods. This paradigm change is demonstrated by the creation of numerous volunteer and government groups dedicated to raising infection control standards. These organizations play an important role in distributing guidelines, delivering training programs, and encouraging the use of innovative infection-prevention technologies.
Therefore, The Asia Pacific region is experiencing a paradigm shift in healthcare delivery as evidenced by the increased presence of outsourcing businesses, rising healthcare costs, and the evolution of healthcare standards and infrastructure. Against this backdrop, demand for infection prevention devices is increasing driven by a combination of factors such as the need to reduce the risk of healthcare-associated infections, voluntary and government efforts to improve infection control standards, and growing awareness among healthcare providers and consumers about the importance of infection prevention. As the area embraces innovation and invests in healthcare infrastructure, the market for infection prevention devices is expected to grow and expand steadily.
Competitive Landscape
The Infection Prevention Devices Market is a dynamic and competitive space characterized by diverse players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.
Some of the prominent players operating in the infection prevention devices market include
- Medline Industries, LP
- Cardinal Health
- Paul Hartmann AG
- Mölnlycke Health Care AB
- The 3M Company
- Braun Melsungen AG
- Coloplast Group
- Becton, Dickinson and Company
- Hollister Incorporated
- Medical Devices Business Services, Inc. (Johnson & Johnson)
 Latest Developments
- In February 2019, Hollister Incorporated introduced the Infyna Chic intermittent catheter, expanding their female hydrophilic catheter range. This innovative catheter offers women who use catheters greater discretion and privacy. This product would be added to the entire Infyna catalog, giving ladies diversity. There are numerous solutions available to fulfill their specific needs.
- In October 2021, 3M Company created a new line of surface disinfection cleaners and wipes for healthcare facilities. The products are designed to meet the growing demand for effective and efficient cleaning and disinfection solutions that prevent the transmission of sickness.
Report Scope
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2021-2031 |
| Growth Rate | CAGR of ~4.62% from 2024 to 2031 |
| Base Year for Valuation | 2024 |
| Historical Period | 2021-2023 |
| Forecast Period | 2024-2031 |
| Quantitative Units | Value in USD Billion |
| Report Coverage | Historical and Forecast Revenue Forecast, Historical and Forecast Volume, Growth Factors, Trends, Competitive Landscape, Key Players, Segmentation Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Players | Medline Industries, LP, Cardinal Health, Paul Hartmann AG, Mölnlycke Health Care AB, The 3M Company, Braun Melsungen AG, Coloplast Group, Becton, Dickinson and Company, Hollister Incorporated |
| Customization | Report customization along with purchase available upon request |
Infection Prevention Devices Market, By Category
Product Type
- Infection Prevention Supplies
- Infection Prevention Services
- Infection Prevention Equipment
End-User
- Hospitals
- Lifescience Industries
- Clinical Laboratories
Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our <a href="https//www.marketresearch.com/contact-us/" rel=
Table of Content
To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )
List Tables Figures
To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy